Overall | 12 011 | 11.1 | 1.3 | 47.2 |
Ethnic group | | | | |
White | 6315 | 11.1 | 1.8 | 47.5 |
South Asian | 3308 | 11.0 | 0.8 | 46.9 |
Black | 1611 | 10.6 | 0.7 | 46.3 |
Other | 443 | 12.4 | 1.1 | 48.1 |
Sex | | | | |
Female | 6809 | 12.3 | 1.7 | 47.3 |
Male | 5202 | 9.4 | 0.9 | 47.1 |
Age | | | | |
18–49 | 861 | 16.6 | 1.4 | 47.5 |
50–59 | 1430 | 16.7 | 2.5 | 49.5 |
60–69 | 2351 | 14.2 | 1.9 | 49.0 |
70–79 | 3954 | 9.6 | 1.1 | 47.1 |
≥80 | 3415 | 6.9 | 0.6 | 45.1 |
|
CKD stage (based on latest eGFR) |
Stage 1 | 22 | 13.6 | 0 | 97.5 |
Stage 2 | 1083 | 14.2 | 2.4 | 65.8 |
Stage 3 | 9639 | 11.5 | 1.3 | 48.6 |
Stage 4 | 897 | 5.5 | 0.5 | 24.0 |
Stage 5 | 362 | 3.0 | 0.3 | 8.7 |
|
Comorbidity status | | | | |
Proteinuria positive | 5022 | 8.7 | 0.7 | 43.6 |
Ischaemic heart disease | 2881 | 7.8 | 0.7 | 45.7 |
Type 2 diabetes mellitus | 4869 | 9.9 | 1.1 | 45.9 |
Stroke/TIA | 774 | 7.5 | 0.8 | 45 |
Hypertension | 9032 | 10.3 | 1.3 | 45.1 |
Arthritis | 4209 | 14.1 | 2.4 | 47.5 |
Chronic pain | 864 | 16.6 | 2.0 | 47.7 |
PPI (as proxy for dyspepsia) | 4888 | 14.2 | 1.9 | 46.5 |
|
Comorbidity count, additional conditions |
None | 1188 | 13.5 | 1.3 | 51.9 |
1 | 3307 | 10.9 | 1.1 | 47.8 |
2 | 4159 | 11.2 | 1.4 | 46.7 |
≥3 | 3357 | 10.2 | 1.5 | 45.5 |